Small Business Innovation Research · Small Business Technology Transfer
Guild Associates Inc: SBIR & STTR awards
18 awards worth $4.54M to 1 companies since 1984 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Guild Associates Inc's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 1 | 0 | $306.7K |
| 2024 | 1 | 0 | $300.0K |
| 2023 | 1 | 0 | $300.0K |
| 2020 | 1 | 0 | $150.0K |
| 2019 | 1 | 0 | $300.0K |
| 2017 | 2 | 0 | $514.2K |
| 2015 | 2 | 0 | $394.4K |
| 2014 | 3 | 0 | $529.1K |
| 2011 | 0 | 1 | $710.9K |
| 2009 | 1 | 1 | $835.2K |
| 2005 | 1 | 0 | $115.9K |
| 1989 | 1 | 0 | $38.3K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| SBIR PHASE I (NIMH TOPIC 3): POINT-OF-CARE AND PHARMACY-BASED ANTIRETROVIRAL DRUG ADHERENCE ASSAYS - POINT-OF-CARE ANTI-RETROVIRAL DRUG ADHERENCE IMPEDANCE SPECTROSCOPY DEVICE · topic 3 | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $306.7K | 2025 |
| NIMH SBIR PHASE I TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS HIV, pre-exposure prophylaxis, antiretroviral therapy, electrochemistry, impedance spectroscopy, viral load, point of care, sensor · topic 1 | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2024 |
| POINT-OF-CARE ELECTROCHEMICAL APTASENSOR FOR LONG-TERM PHARMACOLOGICAL ADHERENCE MONITORING · topic 114 | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2023 |
| Accelerated Detection of Legionellain Water Samples using Electrochemical Impedance-based Devices · topic NCIRD-034-PHS2020 | Guild Associates Inc · Ohio | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $150.0K | 2020 |
| Electrochemical aptasensor for Anti-Tuberculosis antibiotic quantification · topic NIAID | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2019 |
| Phage accelerated test system for ID AST of urinary tract infections · topic R | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $291.1K | 2017-08-15 |
| LUMIPHAGE DIRECT ID AST OF URINARY TRACT INFECTIONS · topic NIAID | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $223.0K | 2017 |
| Molecularly self-assembled multi-functional DNA Origami nanostructure for safe and effective siRNA delivery · topic 100 | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $170.7K | 2014-12-01 |
| IGF OT IGF "PHAGE FUNCTIONALIZED MICROPILLARDEVICES FOR SELECTIVE BACTERIAL COLLECTION" · topic NIAID | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $223.7K | 2015 |
| Development of novel malaria parastie metabolite-based non-invasive diagnostic biosensor | Guild Associates Inc · Ohio | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $150.0K | 2014-06-08 |
| Affinity reagents for the detection of modified RNAs and Transcriptome-wide mapping of RNA modifications · topic NIDA | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $209.0K | 2014 |
| A novel antisense therapeutic for treatment of Aspergillus fumigatus infections · topic NIAID | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $170.1K | 2014 |
| Phage-mediated bioluminescent detection of Yersinia pestis · topic NIAID | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $710.9K | 2011 |
| In vivo profiling for oral candidiasis drug target discovery | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $724.5K | 2009 |
| Phage-mediated bioluminescent detection of Yersinia pestis. | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $110.8K | 2009 |
| Identifying targets for diagnosing oral candidiasis | Guild Associates Inc · Ohio | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $115.9K | 2005 |
| NOVEL NEURAL NETWORK DEVICE | Guild Associates Inc · Ohio | Department of Health and Human Services | SBIR Phase I | $38.3K | 1989 |
| THE PROPOSED WORK IS INTENDED TO DEMONSTRATE THE TECHNICAL FEASIBILITY OF DEVELOPING A TRULY WEARABLE, CONTINUOUSLY FUNCTIONING ARTIFICIAL KIDNEY BY MEANS OF GUILD ASSOCIATES PROPRIETARY UNDERSTANDING OF ADVANCED ADSORPTION TECHNOLOGY. | Guild Associates Inc · Ohio | Department of Health and Human Services | SBIR Phase I | $50.0K | 1984 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.